Literature DB >> 25139297

Comparative analysis of gender-related differences in symptoms and referral patterns prior to initial diagnosis of urothelial carcinoma of the bladder: a prospective cohort study.

Atiqullah Aziz1, Stephan Madersbacher, Wolfgang Otto, Roman Mayr, Evi Comploj, Armin Pycha, Stefan Denzinger, Hans-Martin Fritsche, Maximilian Burger, Michael Gierth.   

Abstract

OBJECTIVE: To analyze gender-specific differences regarding clinical symptoms, referral patterns and tumor biology prior to initial diagnosis of urothelial carcinoma of the bladder (UCB).
METHODS: A consecutive series of patients with an initial diagnosis of UCB was included. All patients completed a questionnaire on demographics, clinical symptoms and referral patterns.
RESULTS: In total, 68 patients (50 men, 18 women) with newly diagnosed UCB at admission for transurethral resection of bladder tumors were recruited. Dysuria was more often observed in women (55.6 vs. 38.0%, p = 0.001). Direct consultation of the urologist was conducted by 84.0% of males and 66.7% of females (p = 0.120). One third of the women saw their general practitioner and/or gynecologist once or twice (p = 0.120) before referral to the urologist. Furthermore, women were significantly more often treated for urinary tract infections than men (61.1 vs. 20.0%, p = 0.005). Cystoscopy at first presentation to the urologist was more often performed in men than women (88.0 vs. 66.7%, p = 0.068), with a more favorable tumor detection rate at first cystoscopy in men (96.0 vs. 50.0%, p < 0.001).
CONCLUSIONS: Delayed referral patterns might lead to deferred diagnosis of UCB and consequently to adverse outcome. Thus, primary care physicians might consider referring patients with bladder complaints to specialized care earlier.
© 2014 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2014        PMID: 25139297     DOI: 10.1159/000363334

Source DB:  PubMed          Journal:  Urol Int        ISSN: 0042-1138            Impact factor:   2.089


  3 in total

Review 1.  Female with bladder cancer: what and why is there a difference?

Authors:  Phillip Marks; Armin Soave; Shahrokh F Shariat; Harun Fajkovic; Margit Fisch; Michael Rink
Journal:  Transl Androl Urol       Date:  2016-10

2.  Improving the Timely Detection of Bladder and Kidney Cancer in Primary Care.

Authors:  Yin Zhou; Garth Funston; Georgios Lyratzopoulos; Fiona M Walter
Journal:  Adv Ther       Date:  2019-05-17       Impact factor: 3.845

3.  Quality of the diagnostic process in patients presenting with symptoms suggestive of bladder or kidney cancer: a systematic review.

Authors:  Yin Zhou; Marije van Melle; Hardeep Singh; Willie Hamilton; Georgios Lyratzopoulos; Fiona M Walter
Journal:  BMJ Open       Date:  2019-10-03       Impact factor: 2.692

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.